PEPFAR-Funded Studies

WRP-N focuses on developing leadership, clinical, laboratory and logistical capabilities within the community to build a sustainable health capacity and infrastructure.

WRP-N has cultivated a strong partnership with the Nigerian Armed Forces to provide antiretroviral therapy (ART) in the context of a comprehensive HIV prevention effort funded by PEPFAR.

In an effort to enhance capacity and improve service delivery to prevent transmission of HIV/AIDs, WRP-N supports prevention programs to interventions to military and civilian populations in NMOD health facilities and barrack communities. Some of the core program areas include community outreach on sexual prevention, biomedical transmission prevention, and HIV counseling and testing. The program also trains point-of-service pharmacists on how to properly dispense ARVs, manage drug combinations and mitigate treatment failures.

WRP-N’s strong partnership with the Nigerian military and its large network of medical facilities and well-trained personnel creates  a supportive climate and framework for program evaluations, surveillance and research.

PEPFAR Research:

RV352 –An evaluation of HIV and Malaria Co-Infection in two Nigerian Military Hospitals. This study is being conducted in two Nigerian Military hospitals namely; 44 Nigerian Army Reference Hospital, Kaduna and 68 Nigerian Army Reference Hospital, Yaba, Lagos.  The study aims to evaluate the impact of malaria co-infection on the course of HIV infection among subjects enrolled for comprehensive HIV care and treatment.

RV329 – AFRICOS – a 15-year study called the African Cohort Study, a longitudinal study to assess the impact of clinical practices, biological factors and socio-behavioral issues on HIV infection and disease progression in an African context.

RV368 – MHRP in collaboration with the Institute of Human Virology (IHV) and Johns Hopkins University began a new cohort study called the TRUST study (RV368) in high-risk populations in Nigeria.